Serum lipoprotein levels, statin use, and cognitive function in older women

Archives of Neurology

Volumn 59, Issue 3, 2002, Pages 378-384

  Yaffe, Kristine ^a,b,c   Barrett Connor, Elizabeth ^d   Lin, Feng ^a   Grady, Deborah ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; CONJUGATED ESTROGEN; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0036186663     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.3.378     Document Type: Article

References (29)

1. Estimated prevalence of Alzheimer's disease in the United States
2. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population-based study of African Americans
3. Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease
4. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly
5. Low-density lipoprotein cholesterol and the risk of dementia with stroke
6. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly: The Bronx Aging study
7. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study
8. Decline in cognitive performance in aging twins: Heritability and biobehavioral predictors from the National Heart, Lung, and Blood Institute Twin study
9. Effects of lovastatin on cognitive function and psychological well-being
10. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance
11. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers
12. Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance
13. Central nervous system effects of HMG CoA reductase inhibitors: Lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia
14. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
15. Statins and the risk of dementia
16. Heart and Estrogen/progestin Replacement Study (HERS): Design, methods, and baseline characteristics
17. Effect of postmenopausal hormone therapy on cognitive function: The Heart and Estrogen/progestin Replacement study
18. The Modified Mini-Mental State (3MS) examination
19. Geriatric Depression Scale: Recent evidence and development of a shorter version
20. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective
21. Women, myocardial infarction, and dementia in the very old
22. Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses: European studies of dementia
23. Effect of pharmacologic lipid lowering on health-related quality of life in older persons: Results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot study
24. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
25. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
26. HMG-CoA reductase inhibitors (statins): A promising approach to stroke prevention
27. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
28. The role of cholesterol in the biosynthesis of β-amyloid
29. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men